Department of Surgery

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Liver Transplantation 52%
3. Living Donors 43%
4. Thyroidectomy 42%
5. Breast 41%
6. Robotics 39%
7. Recurrence 37%
8. Neoplasms 34%
9. Papillary Thyroid Cancer 28%
10. Colorectal Neoplasms 26%
11. Neoplasm Metastasis 26%
12. Tissue Donors 25%
13. Survival 23%
14. Safety 21%
15. Triple Negative Breast Neoplasms 21%
16. Liver 20%
17. Regulatory T-Lymphocytes 19%
18. Registries 18%
19. Lymph Nodes 18%
20. Rectal Neoplasms 18%
21. Colonic Neoplasms 18%
22. Stomach Neoplasms 17%
23. Survival Rate 17%
24. Propensity Score 17%
25. Common Bile Duct 16%
26. Multicenter Studies 15%
27. Estrogen Receptors 15%
28. Therapeutics 15%
29. Transplants 15%
30. Mastectomy 15%
31. Hepatocellular Carcinoma 14%
32. Laparoscopic Cholecystectomy 13%
33. Thyroid Neoplasms 13%
34. Segmental Mastectomy 12%
35. Bile Ducts 12%
36. Drug Therapy 12%
37. Hormones 12%
38. Pancreaticoduodenectomy 11%
39. Thyroid Gland 11%
40. Mutation 11%
41. Postoperative Pain 10%
42. Epithelial-Mesenchymal Transition 10%
43. human ERBB2 protein 10%
44. Confidence Intervals 10%
45. Pancreatectomy 10%
46. Laparoscopy 10%
47. Fluorodeoxyglucose F18 10%
48. Retrospective Studies 10%
49. Kidney Transplantation 10%
50. Graves Disease 10%
51. Tamoxifen 10%
52. Postoperative Complications 10%
53. Hepatectomy 9%
54. Nipples 9%
55. Bile Duct Neoplasms 9%
56. Appendectomy 9%
57. Serum 9%
58. Sentinel Lymph Node Biopsy 9%
59. Disease-Free Survival 9%
60. Carcinoma 9%
61. Odds Ratio 8%
62. Tacrolimus 8%
63. Indocyanine Green 8%
64. Biomarkers 8%
65. Kidney 8%
66. Length of Stay 8%
67. Ductal Carcinoma 8%
68. Transforming Growth Factors 8%
69. Reactive Oxygen Species 8%
70. Mammaplasty 8%
71. Letrozole 8%
72. Biopsy 8%
73. Adenocarcinoma 8%
74. Neuroendocrine Tumors 8%
75. Adjuvant Chemotherapy 7%
76. Pancreatic Neoplasms 7%
77. Randomized Controlled Trials 7%
78. Organ Transplantation 7%
79. Body Mass Index 7%
80. Margins of Excision 7%
81. Meta-Analysis 7%
82. Incidence 7%
83. Microbiota 7%
84. Hemorrhoids 7%
85. Databases 7%
86. alpha-Fetoproteins 7%
87. Multivariate Analysis 7%
88. Transplant Recipients 7%
89. Ligation 7%
90. Surgeons 7%
91. Cell Line 7%
92. Intussusception 6%
93. Colitis 6%
94. Pain 6%
95. Familial Breast Cancer 6%
96. Transplantation 6%
97. Ovarian Neoplasms 6%
98. Lymph Node Excision 6%
99. Matrix Metalloproteinase 7 6%
100. Biliary Tract Neoplasms 6%